632 related articles for article (PubMed ID: 33375371)
1. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19.
Bernard I; Limonta D; Mahal LK; Hobman TC
Viruses; 2020 Dec; 13(1):. PubMed ID: 33375371
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
[TBL] [Abstract][Full Text] [Related]
3. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
Elife; 2020 Apr; 9():. PubMed ID: 32338605
[TBL] [Abstract][Full Text] [Related]
4. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.
Amraei R; Rahimi N
Cells; 2020 Jul; 9(7):. PubMed ID: 32660065
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.
Kumar A; Narayan RK; Kumari C; Faiq MA; Kulandhasamy M; Kant K; Pareek V
Med Hypotheses; 2020 Dec; 145():110320. PubMed ID: 33032170
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19.
Rodríguez C; Luque N; Blanco I; Sebastian L; Barberà JA; Peinado VI; Tura-Ceide O
Am J Respir Cell Mol Biol; 2021 Apr; 64(4):407-415. PubMed ID: 33180562
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
Datta PK; Liu F; Fischer T; Rappaport J; Qin X
Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
[TBL] [Abstract][Full Text] [Related]
8. Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury.
Rossouw TM; Anderson R; Manga P; Feldman C
Front Immunol; 2022; 13():776861. PubMed ID: 35185878
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis.
Bhargavan B; Kanmogne GD
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142345
[TBL] [Abstract][Full Text] [Related]
10. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.
Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID-19 disease.
Khoury EE; Knaney Y; Fokra A; Kinaneh S; Azzam Z; Heyman SN; Abassi Z
J Cell Mol Med; 2021 Apr; 25(8):3840-3855. PubMed ID: 33660945
[TBL] [Abstract][Full Text] [Related]
12. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection.
Maiuolo J; Mollace R; Gliozzi M; Musolino V; Carresi C; Paone S; Scicchitano M; Macrì R; Nucera S; Bosco F; Scarano F; Zito MC; Ruga S; Tavernese A; Mollace V
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291346
[TBL] [Abstract][Full Text] [Related]
13. Comparison of SARS-CoV-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells.
Benedetti F; Silvestri G; Mavian C; Weichseldorfer M; Munawwar A; Cash MN; Dulcey M; Vittor AY; Ciccozzi M; Salemi M; Latinovic OS; Zella D
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834998
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
[TBL] [Abstract][Full Text] [Related]
16. Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases.
Tanzadehpanah H; Lotfian E; Avan A; Saki S; Nobari S; Mahmoodian R; Sheykhhasan M; Froutagh MHS; Ghotbani F; Jamshidi R; Mahaki H
Biomed Pharmacother; 2023 Oct; 166():115321. PubMed ID: 37597321
[TBL] [Abstract][Full Text] [Related]
17. Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection.
Rochette L; Ghibu S
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360751
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.
Suzuki YJ; Nikolaienko SI; Dibrova VA; Dibrova YV; Vasylyk VM; Novikov MY; Shults NV; Gychka SG
Vascul Pharmacol; 2021 Apr; 137():106823. PubMed ID: 33232769
[TBL] [Abstract][Full Text] [Related]
19. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
J Genet; 2021; 100(1):. PubMed ID: 33707363
[TBL] [Abstract][Full Text] [Related]
20. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
